|
SEATTLE, WASHINGTON--(Marketwired - May 6, 2013) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSX VENTURE:VPT) (OTCQX:VPTDF) announces that it intends to complete a non-brokered private placement of up to 1,000 units ("Units") of the Company at a price of USD$1,000 per Unit for gross proceeds of up to USD$1,000,000 (the "Unit Private Placement"). Each Unit will consist of USD$1,100 principal amount of non-convertible secured debentures ("Unit Debentures"), which shall mature three years from the date of issuance and 2,000 common shares in the capital of the Company (the "Common Shares"). |
